Brokers Suggest Investing in Novo Nordisk (NVO): Read This Before Placing a BetZacks Investment Research • 06/18/24
Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease at the 84th Scientific Sessions of the American Diabetes AssociationGlobeNewsWire • 06/18/24
Earnings Growth & Price Strength Make Novo Nordisk (NVO) a Stock to WatchZacks Investment Research • 06/14/24
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity DrugThe Motley Fool • 06/14/24
ASML, Novo Nordisk, Spotify Boast This Sign Of Stock Market LeadershipInvestors Business Daily • 06/12/24
Here is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending StockZacks Investment Research • 06/10/24
Meet The International Megacaps That 'Match Or Surpass' Magnificent Seven StocksInvestors Business Daily • 06/10/24
Novo Nordisk's Ozempic sales double to $700 M in China, driven by weight-loss demandInvezz • 06/06/24